Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, United States.
Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, PA, United States.
Photochem Photobiol. 2020 Mar;96(2):426-433. doi: 10.1111/php.13226. Epub 2020 Mar 20.
As part of a preclinical trial for the treatment of peritoneal carcinomatosis (PC) with photodynamic therapy (PDT), we have assessed changes in optical properties, tissue oxygenation and drug concentration as a result of benzoporphyrin derivative (BPD)-mediated PDT using diffuse reflectance and fluorescence measurements. PDT can effectively treat superficial disease spread, but treatment efficacy is influenced by physical properties of the treated tissue which can change over the treatment time. In this study, healthy canines were given BPD and irradiated with 690 nm light during a partial bowel resection, and spectroscopic and fluorescence measurements were made using an in-house built spectroscopic probe. Hemoglobin concentration, oxygenation and optical properties were determined to be highly heterogeneous between canines and at different anatomical locations within the same subject, so further development of PDT dosimetry systems will need to address this patient and location-specific dose optimization. Compared to other photosensitizers, we found no apparent BPD photobleaching after PDT.
作为光动力疗法(PDT)治疗腹膜癌病(PC)的临床前试验的一部分,我们使用漫反射和荧光测量评估了苯并卟啉衍生物(BPD)介导的 PDT 引起的光学特性、组织氧合和药物浓度的变化。PDT 可以有效地治疗浅表疾病的扩散,但治疗效果受治疗组织的物理特性影响,这些特性在治疗过程中会发生变化。在这项研究中,健康犬在部分肠道切除术中给予 BPD 并接受 690nm 光照射,使用内部构建的光谱探针进行光谱和荧光测量。血红蛋白浓度、氧合和光学特性在犬之间以及同一受体内的不同解剖位置高度不均匀,因此需要进一步开发 PDT 剂量测定系统来解决患者和特定部位的剂量优化问题。与其他光敏剂相比,我们发现 PDT 后 BPD 没有明显的光漂白。